An overview of the benefits and drawbacks of inhaled corticosteroids in chronic obstructive pulmonary disease.
about
Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysisLong-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: an overview and network meta-analysisCombined corticosteroid and long-acting beta(2)-agonist in one inhaler versus long-acting beta(2)-agonists for chronic obstructive pulmonary diseaseLong-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysisThe effect of adding inhaled corticosteroids to tiotropium and long-acting beta(2)-agonists for chronic obstructive pulmonary diseaseInhaled corticosteroid use in patients with chronic obstructive pulmonary disease and the risk of pneumonia: a retrospective claims data analysis.Inhaled corticosteroids in chronic obstructive pulmonary disease: a pro-con perspective.Overtreatment of COPD with inhaled corticosteroids--implications for safety and costs: cross-sectional observational study.LANTERN: a randomized study of QVA149 versus salmeterol/fluticasone combination in patients with COPD.The effect of budesonide on orthodontic induced root resorption.Self-reported osteoporosis prevention in inhaled corticosteroid users in community pharmacy settingOutcome of Inhaler Withdrawal in Patients Receiving Triple Therapy for COPD.Blood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPDVitamin D should be supplemented more actively in elderly patients with coronary heart disease combined with COPD.Is 'GOLD' standard for the management of COPD in clinical practice?Budesonide/formoterol Turbuhaler®: a review of its use in chronic obstructive pulmonary disease.Inhaled corticosteroids and the increased risk of pneumonia.The pharmacological approach to the elderly COPD patient.Meta-review: adverse effects of inhaled corticosteroids relevant to older patients.Optimizing Treatment of Elderly COPD Patients: What Role for Inhaled Corticosteroids?The place of inhaled corticosteroids in the treatment of chronic obstructive pulmonary disease: a narrative review.Use of ICS in COPD: From Blockbuster Medicine to Precision Medicine.Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease: How Significant is the Risk of Pneumonia and Should It Impact Use of Inhaled Corticosteroids?Long-term follow-up in dogs with idiopathic eosinophilic bronchopneumopathy treated with inhaled steroid therapy.
P2860
Q24197853-27A92DB1-C6D2-4312-A19E-234D3DC328F6Q24197946-96569239-A4D4-481B-A8CD-A6BBD2B09F4FQ24200446-D66D244E-BBC4-4E49-B4F2-EE2FF9B3CAEFQ24202279-37328ADA-4A14-44B8-B674-D046788B674AQ24234343-3965F251-2F92-4198-BB8A-1A1A1E616F39Q30654188-293D3712-A593-4671-BF7D-9273304C7349Q34065276-CE3BAF59-CAC4-453B-A70D-D3E8FD9B6801Q35032254-998AC11D-9A76-43F2-B29F-6C66ED52150CQ35703517-4C41EE0F-F17B-4666-9009-172430E76C60Q35942910-5EDC0B27-7BBF-4F7C-8338-C7FA4D579F9FQ36372071-3A4FF7C7-D413-4358-A601-F90B28DF9383Q36431478-EB5DEFFE-6956-4595-B321-F33298F1AEC1Q36577253-D2E29615-A376-46DC-92D5-0150E780580CQ37042538-21ED227E-957D-4175-8100-380916A7738EQ37450159-342C8B3A-23CD-4924-ACA4-EEEC96864034Q37982436-0E116E2C-E360-44C8-87D6-793056C2823AQ38085103-79B0BBE6-C432-4FFA-9C12-6AD007731E62Q38098479-76D37FB6-A2A9-4578-9371-A4BA9617FE3CQ38198574-24FCAFB8-AC35-4FE5-951A-EB5B4B2019DAQ38571581-82816118-A642-4E7C-BF67-C627A7C3D5DDQ38827675-71A3A88A-CF15-485E-A6DE-A6B20CF94A03Q47718704-3577864A-B2EA-46CF-B11C-194D609B0357Q48312856-9EAE7EAB-0F38-4AE2-ADCB-61739BFC4528Q54409679-85D0FB28-45BE-4832-94FC-DFEB881B9079
P2860
An overview of the benefits and drawbacks of inhaled corticosteroids in chronic obstructive pulmonary disease.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
An overview of the benefits an ...... obstructive pulmonary disease.
@ast
An overview of the benefits an ...... obstructive pulmonary disease.
@en
An overview of the benefits an ...... obstructive pulmonary disease.
@nl
type
label
An overview of the benefits an ...... obstructive pulmonary disease.
@ast
An overview of the benefits an ...... obstructive pulmonary disease.
@en
An overview of the benefits an ...... obstructive pulmonary disease.
@nl
prefLabel
An overview of the benefits an ...... obstructive pulmonary disease.
@ast
An overview of the benefits an ...... obstructive pulmonary disease.
@en
An overview of the benefits an ...... obstructive pulmonary disease.
@nl
P2860
P356
P1476
An overview of the benefits an ...... obstructive pulmonary disease.
@en
P2093
Sonal Singh
Yoon K Loke
P2860
P304
P356
10.2147/COPD.S6942
P407
P577
2010-08-09T00:00:00Z